Xencor (XNCR) Non-Current Assets (2013 - 2026)

Xencor's (XNCR) quarterly Non-Current Assets came in at $254.0 million in Q1 2026, down 33.76% year-on-year from $383.4 million in Q1 2025, and down 7.87% on a QoQ basis from $275.7 million in Q4 2025.

Xencor (XNCR) Non-Current Assets (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Non-Current Assets data on file, last reported at $254.0 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 33.76% year-over-year to $254.0 million in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 13.44% decrease from a year earlier, with the FY2025 full-year figure at $275.7 million, down 26.36% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $254.0 million, down from $275.7 million in the prior quarter.
  • Over the last five years, Non-Current Assets for XNCR reached as high as $410.3 million in Q3 2024 and fell as low as $167.3 million in Q3 2022.
  • Historically, Non-Current Assets has averaged $285.8 million across 5 years, with a median of $275.7 million in 2025.
  • On a YoY basis, Non-Current Assets climbed as much as 246.52% in 2022 and fell as far as 58.7% in 2022.
  • Year by year, Non-Current Assets stood at $170.9 million in 2022, then jumped by 92.79% to $329.5 million in 2023, then rose by 13.6% to $374.3 million in 2024, then retreated by 26.36% to $275.7 million in 2025, then fell by 7.87% to $254.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $254.0 million in Q1 2026, $275.7 million in Q4 2025, and $350.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Xencor 1.47 Bn 1.09 Bn - 253.99 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 253.99 Mn
Dec 31, 2025 275.67 Mn
Sep 30, 2025 350.37 Mn
Jun 30, 2025 366.27 Mn
Mar 31, 2025 383.42 Mn
Dec 31, 2024 374.34 Mn
Sep 30, 2024 410.31 Mn
Jun 30, 2024 271.70 Mn
Mar 31, 2024 322.00 Mn
Dec 31, 2023 329.53 Mn
Sep 30, 2023 207.25 Mn
Jun 30, 2023 184.56 Mn
Mar 31, 2023 173.44 Mn
Dec 31, 2022 170.92 Mn
Sep 30, 2022 167.27 Mn
Jun 30, 2022 265.39 Mn
Mar 31, 2022 351.95 Mn
Dec 31, 2021 413.84 Mn
Sep 30, 2021 367.64 Mn
Jun 30, 2021 214.64 Mn